These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30653217)
1. Multiple Lesions in Irradiated Skin. Wetzel M; Jung JY; Brown TS JAMA Oncol; 2019 May; 5(5):728-729. PubMed ID: 30653217 [No Abstract] [Full Text] [Related]
2. Extensive thoracic skin lesion in a patient with history of breast cancer. López Rojo I; Rivas Fidalgo S; Gómez Valdazo A; Díaz Miguel M Cir Esp (Engl Ed); 2019; 97(6):346. PubMed ID: 30595224 [No Abstract] [Full Text] [Related]
3. Vismodegib in advanced basal-cell carcinoma. Babacan T; Sarici F; Altundag K N Engl J Med; 2012 Sep; 367(10):969-70; author reply 970. PubMed ID: 22931270 [No Abstract] [Full Text] [Related]
4. Indications and limitations of vismodegib for basal cell carcinoma. Yin VT; Sniegowski M; Esmaeli B JAMA Ophthalmol; 2014 Jul; 132(7):905-6. PubMed ID: 25010179 [No Abstract] [Full Text] [Related]
5. Vismodegib in advanced basal-cell carcinoma. Henkin RI N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271 [No Abstract] [Full Text] [Related]
6. Attacking the hedgehog pathway: video game or novel skin cancer therapy? DiBaise M JAAPA; 2014 Oct; 27(10):52-3. PubMed ID: 25251656 [No Abstract] [Full Text] [Related]
7. Indications and limitations of vismodegib for basal cell carcinoma--reply. Gill HS; Moscato EE; Silkiss RZ JAMA Ophthalmol; 2014 Jul; 132(7):906. PubMed ID: 25010181 [No Abstract] [Full Text] [Related]